- Home
- FENC vs TEAF Comparison
FENC vs TEAF Comparison
Compare FENC & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- TEAF
- Stock Information
- Founded
- FENC 1996
- TEAF 2017
- Country
- FENC United States
- TEAF United States
- Employees
- FENC N/A
- TEAF N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- FENC Health Care
- TEAF Finance
- Exchange
- FENC Nasdaq
- TEAF Nasdaq
- Market Cap
- FENC 234.9M
- TEAF 158.9M
- IPO Year
- FENC 2001
- TEAF N/A
- Fundamental
- Price
- FENC $8.24
- TEAF $11.81
- Analyst Decision
- FENC Strong Buy
- TEAF
- Analyst Count
- FENC 2
- TEAF 0
- Target Price
- FENC $13.50
- TEAF N/A
- AVG Volume (30 Days)
- FENC 77.1K
- TEAF 56.1K
- Earning Date
- FENC 11-06-2025
- TEAF 01-01-0001
- Dividend Yield
- FENC N/A
- TEAF 9.20%
- EPS Growth
- FENC N/A
- TEAF N/A
- EPS
- FENC N/A
- TEAF N/A
- Revenue
- FENC $33,302,000.00
- TEAF N/A
- Revenue This Year
- FENC $0.18
- TEAF N/A
- Revenue Next Year
- FENC $52.59
- TEAF N/A
- P/E Ratio
- FENC N/A
- TEAF N/A
- Revenue Growth
- FENC N/A
- TEAF N/A
- 52 Week Low
- FENC $3.96
- TEAF $11.11
- 52 Week High
- FENC $9.92
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- FENC 41.49
- TEAF 46.31
- Support Level
- FENC $8.21
- TEAF $11.61
- Resistance Level
- FENC $8.90
- TEAF $11.99
- Average True Range (ATR)
- FENC 0.39
- TEAF 0.15
- MACD
- FENC -0.12
- TEAF 0.00
- Stochastic Oscillator
- FENC 7.02
- TEAF 46.51
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Sustainable and Social Impact Term Fund Formerly Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.